Western tradition · Metabolite

Alpha-Ketoglutarate (AKG)

A TCA-cycle metabolite that suppresses mTOR, co-factors DNA demethylation, and showed biological-age reduction in a 2023 human RCT.

↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.

Origin & tradition

Not traditional: AKG is an endogenous metabolite now studied as a longevity supplement.

Why longevity buyers care

Key active: Alpha-ketoglutarate — TCA cycle metabolite & mTOR suppressor.

AKG is a co-substrate for TET enzymes (DNA demethylation) and an mTOR suppressor. A 2023 RCT by Rejuvant found a median 5.1-year reduction in biological (epigenetic) age over 7 months in older adults. Animal studies show lifespan extension in flies and worms.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Biological age markers (epigenetic)DecreasesMinorC
TET enzyme DNA methylation activityIncreasesModerateC
Healthspan (animal models)IncreasesModerateD
Muscle recovery (sports use)IncreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Alpha-Ketoglutarate (AKG) is typically used

Typical dose
1,000–3,000 mg/day
Form
capsule or powder (AKG or Ca-AKG)
Timing
morning or pre-meal

Ca-AKG (calcium alpha-ketoglutarate) is the most-studied form for longevity. Bryan Johnson's Blueprint protocol uses 2g/day. AKG is also a standard sports supplement at 2–6g around exercise.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

73Evidence confidence
Extensive human-trial evidence102 randomized controlled trials · 106 meta-analyses / systematic reviews

Promising early human RCT (epigenetic age); strong preclinical

AKG is a co-substrate for TET enzymes (DNA demethylation) and an mTOR suppressor. A 2023 RCT by Rejuvant found a median 5.1-year reduction in biological (epigenetic) age over 7 months in older adults. Animal studies show lifespan extension in flies and worms.

21registered clinical trials reference this intervention
    3selected from 3+ PubMed papers (longevity / aging angle)
    Key active: Alpha-ketoglutarate — TCA cycle metabolite & mTOR suppressor.

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Compare the evidence

    Related ingredients

    Suppliers

    No Alpha-Ketoglutarate (AKG) suppliers listed yet

    Tell us what you need and we will source suppliers for you.

    Request sourcing help